CCI suspects Monsanto abused dominant position

Image
Reuters NEW DELHI
Last Updated : Feb 17 2016 | 8:58 PM IST

By Krishna N. Das

NEW DELHI (Reuters) - Competition Commission of India (CCI), India's antitrust regulator, said on Wednesday it suspected that a Monsanto joint venture had abused its dominant position as a supplier of genetically modified (GM) cotton seeds in the country.

Local farmers and some of their associations, including one affiliated to Prime Minister Narendra Modi's ruling party, have complained that Monsanto overprices its products using its position as the supplier of GM seeds used in more than 90 percent of the country's cotton cultivation.

U.S.-based Monsanto launched a GM cotton variety in India in 2002 despite opposition from critics who questioned its safety, transforming the country into the world's top producer and second-largest exporter of the fibre.

Mahyco Monsanto Biotech (India) (MMB), a joint venture with India's Mahyco, licenses a gene that produces its own pesticide to a number of local seed companies in lieu of royalties and an upfront payment. MMB also markets the seeds directly, though the local licensees together command 90 percent of the market.

Acting on a complaint by India's agriculture ministry that the JV was charging "unreasonably high" royalty fees, CCI asked its director general (DG) to complete an investigation into the matter in two months.

"The DG shall also investigate the role of the officials/ persons who at the time of such contravention (of the competition act, if any) were in charge of and responsible for the conduct of their business," the CCI wrote in an order uploaded on its website. (https://bit.ly/1oJw4Jg)

An MMB spokesman had no immediate comment, but its counsel told the CCI that the royalty charged from Indian seed companies was the lowest in the world, that prices had come down over time and innovation had to be rewarded, according to the order.

A minister involved in the issue told Reuters the government was determined to lower GM cotton prices ahead of a possible launch of GM mustard, final trial reports for which are being examined by experts.

A committee of government and independent experts this month sought more information from a team of Indian scientists who have spent almost a decade on laboratory and field trials for the mustard crop, which could become the country's first transgenic food crop.

(Additional eporting by Rupam Jain and Mayank Bhardwaj; Editing by Dale Hudson)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 17 2016 | 8:44 PM IST

Next Story